Neocannbio
PrivateLast Round
Series B
Sep 26, 2023
Est. Valuation
$40.6M
Total Funding Raised
$10.7M
Company Overview
Neocannbio is a biotechnology company that develops cannabinoid-based pharmaceutical raw materials and treatments for intractable diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neocannbio Comparables
Compare Neocannbio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ZYUS Life Sciences Corporation | 78% | |
| Avicanna Inc. | 77% | |
| InMed Pharmaceuticals | 77% |
Neocannbio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 26, 2023 | ||||
| Series A | Jul 26, 2022 |
Neocannbio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KT&G | Series A |
| Bilanx Investment | Series B |
| QUAD Investment Management | Series B |
| HLB Investment | Series B |
| Hyundai Technology Investment | Series A |
| Medytox Venture Investment | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 26, 2023
$7.4M round led by QUAD Investment Management and Bilanx Investment.
- Jul 26, 2022
$3.3M round with participation from KT&G and Hyundai Technology Investment.
Recent news
Latest coverage and updates
- expands_facilitiesSep 15, 2026
Neocannbio Co., Ltd. will expand facilities to Andong, South Korea, Eastern Asia, Asia on Oct 1st '26.
- launchesSep 15, 2026
Neocannbio Co., Ltd. launched microwave-based extraction technology on Jul 1st '21.
Neocannbio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neocannbio's valuation, stock price, and market status.
Is Neocannbio a public or private company?
Neocannbio is a private company.
What is the current stock price of Neocannbio?
Neocannbio is a private company with no public stock price. Caplight tracks Neocannbio's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Neocannbio worth (valuation)?
Neocannbio's valuation is estimated at $40.6M based on funding round data.
Can I buy Neocannbio stock?
Neocannbio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Neocannbio's last funding round?
Neocannbio's most recent funding round was Series B on September 26, 2023.
Who are the main investors in Neocannbio?
Key investors in Neocannbio include Bilanx Investment, QUAD Investment Management.
Will Neocannbio IPO soon?
No public IPO plans have been announced for Neocannbio.
How can I track Neocannbio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neocannbio's secondary market activity and sign up for updates.